← 返回

NK 细胞在 EBV 相关鼻咽癌肿瘤免疫微环境中的作用

英文原题:The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma.

查看英文原题

The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma.

PubMed 2024/03/28(内容时间) Cancers (Basel) Q2 · IF 4.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

地方性鼻咽癌(NPC)与EB病毒(EBV)密切相关;EBV促进肿瘤发生并影响NPC肿瘤免疫微环境(TIME)。自然杀伤(NK)细胞属于先天免疫系统,在应对病毒感染和恶性细胞转化方面发挥关键作用。值得注意的是,NK细胞具有独特能力,可不依赖主要组织相容性复合体I类(MHC I)表达靶向肿瘤细胞。这意味着,能够逃避免疫T细胞有效攻击的MHC I缺失肿瘤细胞,仍易受NK细胞介导的杀伤。NK细胞活化取决于其表面抑制性和活化性受体产生的信号。理解NK细胞在复杂EBV⁺ NPC TIME中的作用至关重要。本文全面总结了当前对NPC中NK细胞的认识,重点讨论其亚群、在TIME中的相互作用及细胞毒性,并探讨NK细胞在NPC中的潜在转化治疗应用。本综述旨在增进对NK细胞在NPC中作用的认识,并为未来研究提供有价值见解。

展开英文摘要原文

Endemic nasopharyngeal carcinoma (NPC) is closely associated with the Epstein-Barr virus (EBV), which contributes to tumor development and influences the tumor immune microenvironment (TIME) in NPC. Natural killer (NK) cells, as part of the innate immune system, play a crucial role in responding to viral infections and malignant cell transformations.

Notably, NK cells possess a unique ability to target tumor cells independent of major histocompatibility complex class I (MHC I) expression. This means that MHC I-deficient tumor cells, which can escape from effective T cell attack, are susceptible to NK-cell-mediated killing.

The activation of NK cells is determined by the signals generated through inhibitory and activating receptors expressed on their surface. Understanding the role of NK cells in the complex TIME of EBV + NPC is of utmost importance. In this review, we provide a comprehensive summary of the current understanding of NK cells in NPC, focusing on their subpopulations, interactions, and cytotoxicity within the TIME.

Moreover, we discuss the potential translational therapeutic applications of NK cells in NPC. This review aims to enhance our knowledge of the role of NK cells in NPC and provide valuable insights for future investigations.

论文信息

作者
Li S、Dai W、Kam NW、Zhang J、Lee VHF、Ren X、Kwong DL
第一作者单位
Department of Biotherapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.China
通讯作者单位
Department of Clinical Oncology, Centre of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China.Hong Kong
文献类型
综述
期刊
Cancers2024 Mar 28
原文标识
PubMed 38610990 · DOI 10.3390/cancers16071312